C07C 233/74
With the substituted hydrocarbon radical bound to the nitrogen atom of the
Official title: with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
C07C233/74 (With the substituted hydrocarbon radical bound to the nitrogen atom of the) appears on 48 US grants and 45 published applications in this corpus.
Search patents in C07C- Granted patents
- 48
- Published applications
- 45
- Assignees
- 42
- Inventors
- 208
- Latest grant
- 9 Feb 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 0 | 0 |
| 1999 | 5 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 4 |
| 2003 | 3 | 4 |
| 2004 | 2 | 2 |
| 2005 | 1 | 1 |
| 2006 | 1 | 2 |
| 2007 | 3 | 2 |
| 2008 | 1 | 2 |
| 2009 | 0 | 1 |
| 2010 | 4 | 4 |
| 2011 | 1 | 2 |
| 2012 | 2 | 0 |
| 2013 | 2 | 3 |
| 2014 | 3 | 3 |
| 2015 | 1 | 1 |
| 2016 | 0 | 3 |
| 2017 | 1 | 2 |
| 2018 | 4 | 2 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Modulators of the integrated stress pathway9 Feb 2021US 10,913,727 B2AbbVie Inc.
- Immunoregulatory agents19 Feb 2019US 10,206,893 B2Flexus Biosciences, Inc.
- SHIP1 modulators and methods related thereto16 Oct 2018US 10,100,056 B2Aquinox Pharmaceuticals (Canada) Inc.
- Process for the preparation of a spiroheterocyclic pyrrolidine dione9 Oct 2018US 10,093,672 B2Syngenta Participations AG
- Process for the preparation of spiroheterocyclic pyrrolidine diones15 May 2018US 9,969,734 B2Syngenta Participations AG
- Pharmaceutical composition for preventing or treating mental disorder30 Oct 2025US 2025/0332138 A1Vivozon Inc.
- Deuterated dhodh inhibitors20 Jun 2024US 2024/0199535 A1Immunic AG
- Compound for capping layer and organic light emitting device including same13 Jun 2024US 2024/0190811 A1Dongjin Semichem Co., Ltd.
- Modulators of the integrated stress pathway7 Apr 2022US 2022/0106281 A1AbbVie Inc.
- N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1] pentan-1-yl)-2-cyclobutane-1- carboxamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases20 May 2021US 2021/0145771 A1GlaxoSmithKline Intellectual Property Development Limited
Most cited
By later US patents
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives68US 5,877,218 ATeva Pharmaceutical Industries Ltd. · 1999
- Substituted 2-amidotetralins as melatonin agonists and antagonists41US 5,071,875 ANorthwestern University · 1991
- Substituted 2-amidotetralins as melatonin agonists and antagonists37US 5,151,446 ANorthwestern University · 1992
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives32US 5,914,349 ATeva Pharmaceutical Industries Ltd. · 1999
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives31US 5,877,221 ATechnion Research & Development Foundation Limited · 1999